Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02117577

Ligand	Ligand name	Chain	PDB	Tanimoto
G2G	5-TERT-BUTYL-2-(4-METHYLPHENYL)-3-{[({4-[6-(MORPHOLIN-4-YLMETHYL)PYRIDIN-3-YL]-1-NAPHTHYL}AMINO)CARBONYL]AMINO}-1H-PYRAZOL-2-IUM	A	2PUU	0.72
LZ7	4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	A	2VTN	0.71
LZ1	1H-indazole	A,B	3E6I	0.75
LZ1	1H-indazole	A	2VTA	0.75
5NI	5-NITROINDAZOLE	A,B	1M8I	0.72
5NI	5-NITROINDAZOLE	A,B	1M9Q	0.72
LL1	3-pyridin-4-yl-1H-indazole	A	3DNE	0.77
582	5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE	A	2QHN	0.73
PY1	4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE	A	1PY5	0.73
GG5	4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE	A	3HVC	0.71
306	3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-6-(1H-PYRAZOL-4-YL)QUINOLIN-2(1H)-ONE	A	2HY0	0.72
L0C	4-{[2-(4-{[(4-FLUOROPHENYL)CARBONYL]AMINO}-1H-PYRAZOL-3-YL)-1H-BENZIMIDAZOL-6-YL]METHYL}MORPHOLIN-4-IUM	A	2W1C	0.73
6NI	6-NITROINDAZOLE	A,B	1M8H	0.74
6NI	6-NITROINDAZOLE	A,B	1M9M	0.74
LZ3	N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide	A	2VTI	0.72
NCE	3,6-Bis[(3-morpholinopropionamido)] acridine	A,B	3EM2	0.7
P04	19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one	A	3BE9	0.7
LZE	4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide	A	2VU3	0.72
L0E	4-[(2-{4-[(PHENYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-5-YL)METHYL]MORPHOLIN-4-IUM	A	2W1E	0.77
422	3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE	A	2HXL	0.7
LZ5	N-phenyl-1H-pyrazole-3-carboxamide	A	2VTL	0.74
L0G	2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-6-(MORPHOLIN-4-IUM-4-YLMETHYL)-1H-3,1-BENZIMIDAZOL-3-IUM	A	2W1G	0.77
SBC	1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE	A,C,D	2BKZ	0.72
LZD	4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide	A	2VTT	0.76
740	N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE	A	2R64	0.7
WBT	3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE	A	1WBT	0.72
PPX	[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE	E,H	1QBV	0.7
D31	2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE	A	2B55	0.72
LZ9	{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	A	2VTP	0.73
L0I	4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM	A,B	2W1I	0.77
LZA	{[(2,6-difluorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide	A	2VTQ	0.76